Literature DB >> 11084468

[Contribution of intracervical PGE2 administration in premature rupture of the membranes at term. Prospective randomised clinical trial].

S Hidar1, M Bibi, M Jerbi, S Bouguizene, M Nouira, R Mellouli, A Chaïeb, H Khaïri.   

Abstract

OBJECTIVE: To compare the clinical effectiveness and safety of intracervical dinoprostone versus conservative management of term prelabor rupture of membranes. SUBJECTS AND METHODS: 88 women with term prelabor rupture of membranes were assigned randomly to one of two groups
RESULTS: 44 women were allocated in each group. The means (+/- S. D) intervals from PROM to delivery and from inclusion to start of labour were significantly shorter in the dinoprostone group (19.5+/-6.2 vs 25.5+/-7.7 hours p<0.01 and 8.7+/-5.5 hours vs 14+/-6. 8; p=0.32 respectively). No significant differences were observed in the mean duration of labour (4.5+/-1.6 hours vs. 4.9+/-1.67 p=0.32). The rates of clinical amniotits were 15.9% in the dinoprostone group and 6.8% in the control group; difference is not statistically significant (p=0.17). The mode of delivery and Apgar score were similar in the two groups. Uterine tachysystole occurred more frequently in the dinoprostone group (6.8 vs 0%) but did not reach statistical significance.
CONCLUSION: Intracervical administration of dinoprostone with prelabor rupture of membrane at term and unripened cervix shortens the interval to delivery without a significant increase of maternal or neonatal morbidity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084468

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  2 in total

Review 1.  Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).

Authors:  Philippa Middleton; Emily Shepherd; Vicki Flenady; Rosemary D McBain; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

Review 2.  Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis.

Authors:  Ekaterina Mishanina; Ewelina Rogozinska; Tej Thatthi; Rehan Uddin-Khan; Khalid S Khan; Catherine Meads
Journal:  CMAJ       Date:  2014-04-28       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.